Biomarin Pharmaceutical Q1 Adj. EPS $0.76 Misses $0.79 Estimate, Sales $766.208M Beat $755.610M Estimate

Benzinga Newsdesk www.benzinga.com Positive 77.2%

Neg 0% Neu 0% Pos 77.2%

Comments

No comments yet. Be the first!